BUGWORKS RES INC has a total of 14 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are OP2 Drugs, CYSTIC FIBROSIS FOUND THERAPEUTICS INC and SUMMIT THERAPEUTICS PLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Katagihallimath Nainesh | 11 |
#2 | Bharatham Nagakumar | 11 |
#3 | Sharma Sreevalli | 11 |
#4 | Nandishaiah Radha | 11 |
#5 | Peer Mohamed Shahul Hameed | 11 |
#6 | Ramachandran Vasanthi | 7 |
#7 | Nainesh Katagihallimath | 3 |
#8 | Venkataraman Balasubramanian | 3 |
#9 | Nagakumar Bharatham | 3 |
#10 | Radha Nandishaiah | 3 |
Publication | Filing date | Title |
---|---|---|
EP3774790A1 | Oxazolidinone antibiotic compounds and process of preparation | |
US2021070772A1 | Anti-bacterial heterocyclic compounds and their synthesis | |
CN110382505A | It can be used as the heterocyclic compound and its production method of antibacterial agent | |
MX2018014165A | Heterocyclic compounds useful as anti-bacterial agents and method for production. |